Assessment |
Biopsychology |
Comparative |
Cognitive |
Developmental |
Language |
Individual differences |
Personality |
Philosophy |
Social |
Methods |
Statistics |
Clinical |
Educational |
Industrial |
Professional items |
World psychology |
Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Neuroscience · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology (Index, Outline)
ATC codes |
---|
N Nervous system |
N01 Anesthetics |
N02 Analgesics |
N03 Antiepileptics |
N04 Anti-parkinson drugs |
N05 Psycholeptics |
N06 Psychoanaleptics |
N07 Other nervous system drugs |
ATCvet only |
QN51 Products for animal euthanasia |
Template:ATC codes short |
ATC code N04 Anti-parkinson drugs is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the [[World Health Organization|WHO]ATC code N03] for the classification of drugs and other medical products. Subgroup N04 is part of the anatomical group N Nervous system.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QN04...[2]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
N04A Anticholinergic agents[]
N04AA Tertiary amines[]
- N04AA01 Trihexyphenidyl
- N04AA02 Biperiden
- N04AA03 Metixene
- N04AA04 Procyclidine
- N04AA05 Profenamine
- N04AA08 Dexetimide
- N04AA09 Phenglutarimide
- N04AA10 Mazaticol
- N04AA11 Bornaprine
- N04AA12 Tropatepine
N04AB Ethers chemically close to antihistamines[]
- N04AB01 Etanautine
- N04AB02 Orphenadrine (chloride)
N04AC Ethers of tropine or tropine derivatives[]
- N04AC01 Benzatropine
- N04AC30 Etybenzatropine
N04B Dopaminergic agents[]
N04BA Dopa and dopa derivatives[]
- N04BA01 Levodopa
- N04BA02 Levodopa and decarboxylase inhibitor
- N04BA03 Levodopa, decarboxylase inhibitor and COMT inhibitor
- N04BA04 Melevodopa
- N04BA05 Melevodopa and decarboxylase inhibitor
- N04BA06 Etilevodopa and decarboxylase inhibitor
N04BB Adamantane derivatives[]
- N04BB01 Amantadine
N04BC Dopamine agonists[]
- N04BC01 Bromocriptine
- N04BC02 Pergolide
- N04BC03 Dihydroergocryptine mesylate
- N04BC04 Ropinirole
- N04BC05 Pramipexole
- N04BC06 Cabergoline
- N04BC07 Apomorphine
- N04BC08 Piribedil
- N04BC09 Rotigotine
N04BD Monoamine oxidase B inhibitors[]
- N04BD01 Selegiline
- N04BD02 Rasagiline
N04BX Other dopaminergic agents[]
- N04BX01 Tolcapone
- N04BX02 Entacapone
- N04BX03 Budipine
References[]
- ↑ ATC/DDD Index Template:ATC codes lead/UpdateYear. WHO Collaborating Centre for Drug Statistics Methodology.
- ↑ ATCvet Index Template:ATC codes lead/UpdateYear vet. WHO Collaborating Centre for Drug Statistics Methodology.
Antiparkinson agents (N04) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dopaminergics |
| ||||||||||||
Anticholinergics |
Benzatropine • Biperiden# • Bornaprine • Chlorphenoxamine • Cyrimine • Dexetimide • Dimenhydrinate • Diphenhydramine • Etanautine • Etybenzatropine • Mazaticol • Metixene • Orphenadrine • Phenglutarimide • Piroheptine • Procyclidine • Profenamine • Trihexyphenidyl • Tropatepine | ||||||||||||
Others |
Amantadine • Budipine • Memantine • Rimantadine | ||||||||||||
Template:PharmNavFootnote | |||||||||||||
{| class="navbox collapsible nowraplinks" style="margin:auto; " | |||||||||||||
|
|}
Anti-parkinson drugs: dopaminergic agents (N04B) | |
---|---|
Dopa and derivatives |
Levodopa, Melevodopa, Etilevodopa |
Adamantane derivatives | |
Dopamine agonists |
Apomorphine, Bromocriptine, Cabergoline, Dihydrexidine, Dihydroergocryptine mesylate, Fenoldopam, Lisuride, Pergolide, Piribedil, Pramipexole, Quinpirole, Ropinirole, Rotigotine, SKF 38393, SKF 82958 |
MAOIs | |
Other |
Tolcapone, Entacapone, Budipine |
This page uses Creative Commons Licensed content from Wikipedia (view authors). |